img

Global Nuclear Drug for Therapeutic Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Nuclear Drug for Therapeutic Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.

Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.
Nuclear Drug for Therapeutic report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Nuclear Drug for Therapeutic market is projected to reach US$ 4734 million in 2029, increasing from US$ 1771 million in 2022, with the CAGR of 15.1% during the period of 2024 to 2029. Demand from Thyroid and Bone Metastasis are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Nuclear Drug for Therapeutic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant Radiopharma
Lantheus
Aurobindo Pharma
International Isotopes
Mundipharma
Segment by Type
Radium-223
Lutetium-177
Iodine-131
Other

Segment by Application


Thyroid
Bone Metastasis
Lymphoma
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Nuclear Drug for Therapeutic market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Nuclear Drug for Therapeutic introduction, etc. Nuclear Drug for Therapeutic Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Nuclear Drug for Therapeutic market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Nuclear Drug for Therapeutic
1.1 Nuclear Drug for Therapeutic Market Overview
1.1.1 Nuclear Drug for Therapeutic Product Scope
1.1.2 Nuclear Drug for Therapeutic Market Status and Outlook
1.2 Global Nuclear Drug for Therapeutic Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Nuclear Drug for Therapeutic Market Size by Region (2018-2029)
1.4 Global Nuclear Drug for Therapeutic Historic Market Size by Region (2018-2024)
1.5 Global Nuclear Drug for Therapeutic Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Nuclear Drug for Therapeutic Market Size (2018-2029)
1.6.1 North America Nuclear Drug for Therapeutic Market Size (2018-2029)
1.6.2 Europe Nuclear Drug for Therapeutic Market Size (2018-2029)
1.6.3 Asia-Pacific Nuclear Drug for Therapeutic Market Size (2018-2029)
1.6.4 Latin America Nuclear Drug for Therapeutic Market Size (2018-2029)
1.6.5 Middle East & Africa Nuclear Drug for Therapeutic Market Size (2018-2029)
2 Nuclear Drug for Therapeutic Market by Type
2.1 Introduction
2.1.1 Radium-223
2.1.2 Lutetium-177
2.1.3 Iodine-131
2.1.4 Other
2.2 Global Nuclear Drug for Therapeutic Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Nuclear Drug for Therapeutic Historic Market Size by Type (2018-2024)
2.2.2 Global Nuclear Drug for Therapeutic Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Nuclear Drug for Therapeutic Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Nuclear Drug for Therapeutic Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Nuclear Drug for Therapeutic Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Nuclear Drug for Therapeutic Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Nuclear Drug for Therapeutic Revenue Breakdown by Type (2018-2029)
3 Nuclear Drug for Therapeutic Market Overview by Application
3.1 Introduction
3.1.1 Thyroid
3.1.2 Bone Metastasis
3.1.3 Lymphoma
3.1.4 Other
3.2 Global Nuclear Drug for Therapeutic Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Nuclear Drug for Therapeutic Historic Market Size by Application (2018-2024)
3.2.2 Global Nuclear Drug for Therapeutic Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Nuclear Drug for Therapeutic Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Nuclear Drug for Therapeutic Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Nuclear Drug for Therapeutic Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Nuclear Drug for Therapeutic Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Nuclear Drug for Therapeutic Revenue Breakdown by Application (2018-2029)
4 Nuclear Drug for Therapeutic Competition Analysis by Players
4.1 Global Nuclear Drug for Therapeutic Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nuclear Drug for Therapeutic as of 2022)
4.3 Date of Key Players Enter into Nuclear Drug for Therapeutic Market
4.4 Global Top Players Nuclear Drug for Therapeutic Headquarters and Area Served
4.5 Key Players Nuclear Drug for Therapeutic Product Solution and Service
4.6 Competitive Status
4.6.1 Nuclear Drug for Therapeutic Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bayer
5.1.1 Bayer Profile
5.1.2 Bayer Main Business
5.1.3 Bayer Nuclear Drug for Therapeutic Products, Services and Solutions
5.1.4 Bayer Nuclear Drug for Therapeutic Revenue (US$ Million) & (2018-2024)
5.1.5 Bayer Recent Developments
5.2 Novartis
5.2.1 Novartis Profile
5.2.2 Novartis Main Business
5.2.3 Novartis Nuclear Drug for Therapeutic Products, Services and Solutions
5.2.4 Novartis Nuclear Drug for Therapeutic Revenue (US$ Million) & (2018-2024)
5.2.5 Novartis Recent Developments
5.3 China Isotope & Radiation
5.3.1 China Isotope & Radiation Profile
5.3.2 China Isotope & Radiation Main Business
5.3.3 China Isotope & Radiation Nuclear Drug for Therapeutic Products, Services and Solutions
5.3.4 China Isotope & Radiation Nuclear Drug for Therapeutic Revenue (US$ Million) & (2018-2024)
5.3.5 Dongcheng Recent Developments
5.4 Dongcheng
5.4.1 Dongcheng Profile
5.4.2 Dongcheng Main Business
5.4.3 Dongcheng Nuclear Drug for Therapeutic Products, Services and Solutions
5.4.4 Dongcheng Nuclear Drug for Therapeutic Revenue (US$ Million) & (2018-2024)
5.4.5 Dongcheng Recent Developments
5.5 Q BioMed
5.5.1 Q BioMed Profile
5.5.2 Q BioMed Main Business
5.5.3 Q BioMed Nuclear Drug for Therapeutic Products, Services and Solutions
5.5.4 Q BioMed Nuclear Drug for Therapeutic Revenue (US$ Million) & (2018-2024)
5.5.5 Q BioMed Recent Developments
5.6 Curium Pharmaceuticals
5.6.1 Curium Pharmaceuticals Profile
5.6.2 Curium Pharmaceuticals Main Business
5.6.3 Curium Pharmaceuticals Nuclear Drug for Therapeutic Products, Services and Solutions
5.6.4 Curium Pharmaceuticals Nuclear Drug for Therapeutic Revenue (US$ Million) & (2018-2024)
5.6.5 Curium Pharmaceuticals Recent Developments
5.7 Jubilant Radiopharma
5.7.1 Jubilant Radiopharma Profile
5.7.2 Jubilant Radiopharma Main Business
5.7.3 Jubilant Radiopharma Nuclear Drug for Therapeutic Products, Services and Solutions
5.7.4 Jubilant Radiopharma Nuclear Drug for Therapeutic Revenue (US$ Million) & (2018-2024)
5.7.5 Jubilant Radiopharma Recent Developments
5.8 Lantheus
5.8.1 Lantheus Profile
5.8.2 Lantheus Main Business
5.8.3 Lantheus Nuclear Drug for Therapeutic Products, Services and Solutions
5.8.4 Lantheus Nuclear Drug for Therapeutic Revenue (US$ Million) & (2018-2024)
5.8.5 Lantheus Recent Developments
5.9 Aurobindo Pharma
5.9.1 Aurobindo Pharma Profile
5.9.2 Aurobindo Pharma Main Business
5.9.3 Aurobindo Pharma Nuclear Drug for Therapeutic Products, Services and Solutions
5.9.4 Aurobindo Pharma Nuclear Drug for Therapeutic Revenue (US$ Million) & (2018-2024)
5.9.5 Aurobindo Pharma Recent Developments
5.10 International Isotopes
5.10.1 International Isotopes Profile
5.10.2 International Isotopes Main Business
5.10.3 International Isotopes Nuclear Drug for Therapeutic Products, Services and Solutions
5.10.4 International Isotopes Nuclear Drug for Therapeutic Revenue (US$ Million) & (2018-2024)
5.10.5 International Isotopes Recent Developments
5.11 Mundipharma
5.11.1 Mundipharma Profile
5.11.2 Mundipharma Main Business
5.11.3 Mundipharma Nuclear Drug for Therapeutic Products, Services and Solutions
5.11.4 Mundipharma Nuclear Drug for Therapeutic Revenue (US$ Million) & (2018-2024)
5.11.5 Mundipharma Recent Developments
6 North America
6.1 North America Nuclear Drug for Therapeutic Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Nuclear Drug for Therapeutic Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Nuclear Drug for Therapeutic Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Nuclear Drug for Therapeutic Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Nuclear Drug for Therapeutic Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Nuclear Drug for Therapeutic Market Dynamics
11.1 Nuclear Drug for Therapeutic Industry Trends
11.2 Nuclear Drug for Therapeutic Market Drivers
11.3 Nuclear Drug for Therapeutic Market Challenges
11.4 Nuclear Drug for Therapeutic Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Nuclear Drug for Therapeutic Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Nuclear Drug for Therapeutic Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Nuclear Drug for Therapeutic Market Size Share by Region (2018-2024)
Table 4. Global Nuclear Drug for Therapeutic Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Nuclear Drug for Therapeutic Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Nuclear Drug for Therapeutic Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Nuclear Drug for Therapeutic Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Nuclear Drug for Therapeutic Revenue Market Share by Type (2018-2024)
Table 9. Global Nuclear Drug for Therapeutic Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Nuclear Drug for Therapeutic Revenue Market Share by Type (2024-2029)
Table 11. North America Nuclear Drug for Therapeutic Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Nuclear Drug for Therapeutic Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Nuclear Drug for Therapeutic Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Nuclear Drug for Therapeutic Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Nuclear Drug for Therapeutic Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Nuclear Drug for Therapeutic Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Nuclear Drug for Therapeutic Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Nuclear Drug for Therapeutic Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Nuclear Drug for Therapeutic Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Nuclear Drug for Therapeutic Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Nuclear Drug for Therapeutic Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Nuclear Drug for Therapeutic Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Nuclear Drug for Therapeutic Revenue Market Share by Application (2018-2024)
Table 24. Global Nuclear Drug for Therapeutic Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Nuclear Drug for Therapeutic Revenue Market Share by Application (2024-2029)
Table 26. North America Nuclear Drug for Therapeutic Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Nuclear Drug for Therapeutic Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Nuclear Drug for Therapeutic Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Nuclear Drug for Therapeutic Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Nuclear Drug for Therapeutic Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Nuclear Drug for Therapeutic Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Nuclear Drug for Therapeutic Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Nuclear Drug for Therapeutic Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Nuclear Drug for Therapeutic Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Nuclear Drug for Therapeutic Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Nuclear Drug for Therapeutic Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Nuclear Drug for Therapeutic Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nuclear Drug for Therapeutic as of 2022)
Table 39. Date of Key Players Enter into Nuclear Drug for Therapeutic Market
Table 40. Global Nuclear Drug for Therapeutic Key Players Headquarters and Area Served
Table 41. Nuclear Drug for Therapeutic Product Solution and Service
Table 42. Global Nuclear Drug for Therapeutic Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Bayer Basic Information List
Table 45. Bayer Description and Business Overview
Table 46. Bayer Nuclear Drug for Therapeutic Products, Services and Solutions
Table 47. Revenue (US$ Million) in Nuclear Drug for Therapeutic Business of Bayer (2018-2024)
Table 48. Bayer Recent Developments
Table 49. Novartis Basic Information List
Table 50. Novartis Description and Business Overview
Table 51. Novartis Nuclear Drug for Therapeutic Products, Services and Solutions
Table 52. Revenue (US$ Million) in Nuclear Drug for Therapeutic Business of Novartis (2018-2024)
Table 53. Novartis Recent Developments
Table 54. China Isotope & Radiation Basic Information List
Table 55. China Isotope & Radiation Description and Business Overview
Table 56. China Isotope & Radiation Nuclear Drug for Therapeutic Products, Services and Solutions
Table 57. Revenue (US$ Million) in Nuclear Drug for Therapeutic Business of China Isotope & Radiation (2018-2024)
Table 58. China Isotope & Radiation Recent Developments
Table 59. Dongcheng Basic Information List
Table 60. Dongcheng Description and Business Overview
Table 61. Dongcheng Nuclear Drug for Therapeutic Products, Services and Solutions
Table 62. Revenue (US$ Million) in Nuclear Drug for Therapeutic Business of Dongcheng (2018-2024)
Table 63. Dongcheng Recent Developments
Table 64. Q BioMed Basic Information List
Table 65. Q BioMed Description and Business Overview
Table 66. Q BioMed Nuclear Drug for Therapeutic Products, Services and Solutions
Table 67. Revenue (US$ Million) in Nuclear Drug for Therapeutic Business of Q BioMed (2018-2024)
Table 68. Q BioMed Recent Developments
Table 69. Curium Pharmaceuticals Basic Information List
Table 70. Curium Pharmaceuticals Description and Business Overview
Table 71. Curium Pharmaceuticals Nuclear Drug for Therapeutic Products, Services and Solutions
Table 72. Revenue (US$ Million) in Nuclear Drug for Therapeutic Business of Curium Pharmaceuticals (2018-2024)
Table 73. Curium Pharmaceuticals Recent Developments
Table 74. Jubilant Radiopharma Basic Information List
Table 75. Jubilant Radiopharma Description and Business Overview
Table 76. Jubilant Radiopharma Nuclear Drug for Therapeutic Products, Services and Solutions
Table 77. Revenue (US$ Million) in Nuclear Drug for Therapeutic Business of Jubilant Radiopharma (2018-2024)
Table 78. Jubilant Radiopharma Recent Developments
Table 79. Lantheus Basic Information List
Table 80. Lantheus Description and Business Overview
Table 81. Lantheus Nuclear Drug for Therapeutic Products, Services and Solutions
Table 82. Revenue (US$ Million) in Nuclear Drug for Therapeutic Business of Lantheus (2018-2024)
Table 83. Lantheus Recent Developments
Table 84. Aurobindo Pharma Basic Information List
Table 85. Aurobindo Pharma Description and Business Overview
Table 86. Aurobindo Pharma Nuclear Drug for Therapeutic Products, Services and Solutions
Table 87. Revenue (US$ Million) in Nuclear Drug for Therapeutic Business of Aurobindo Pharma (2018-2024)
Table 88. Aurobindo Pharma Recent Developments
Table 89. International Isotopes Basic Information List
Table 90. International Isotopes Description and Business Overview
Table 91. International Isotopes Nuclear Drug for Therapeutic Products, Services and Solutions
Table 92. Revenue (US$ Million) in Nuclear Drug for Therapeutic Business of International Isotopes (2018-2024)
Table 93. International Isotopes Recent Developments
Table 94. Mundipharma Basic Information List
Table 95. Mundipharma Description and Business Overview
Table 96. Mundipharma Nuclear Drug for Therapeutic Products, Services and Solutions
Table 97. Revenue (US$ Million) in Nuclear Drug for Therapeutic Business of Mundipharma (2018-2024)
Table 98. Mundipharma Recent Developments
Table 99. North America Nuclear Drug for Therapeutic Market Size by Country (2018-2024) & (US$ Million)
Table 100. North America Nuclear Drug for Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 101. Europe Nuclear Drug for Therapeutic Market Size by Country (2018-2024) & (US$ Million)
Table 102. Europe Nuclear Drug for Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 103. Asia-Pacific Nuclear Drug for Therapeutic Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 104. Asia-Pacific Nuclear Drug for Therapeutic Market Size by Region (2018-2024) & (US$ Million)
Table 105. Asia-Pacific Nuclear Drug for Therapeutic Market Size by Region (2024-2029) & (US$ Million)
Table 106. Asia-Pacific Nuclear Drug for Therapeutic Market Share by Region (2018-2024)
Table 107. Asia-Pacific Nuclear Drug for Therapeutic Market Share by Region (2024-2029)
Table 108. Latin America Nuclear Drug for Therapeutic Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 109. Latin America Nuclear Drug for Therapeutic Market Size by Country (2018-2024) & (US$ Million)
Table 110. Latin America Nuclear Drug for Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 111. Middle East & Africa Nuclear Drug for Therapeutic Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 112. Middle East & Africa Nuclear Drug for Therapeutic Market Size by Country (2018-2024) & (US$ Million)
Table 113. Middle East & Africa Nuclear Drug for Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 114. Nuclear Drug for Therapeutic Market Trends
Table 115. Nuclear Drug for Therapeutic Market Drivers
Table 116. Nuclear Drug for Therapeutic Market Challenges
Table 117. Nuclear Drug for Therapeutic Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nuclear Drug for Therapeutic Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Nuclear Drug for Therapeutic Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Nuclear Drug for Therapeutic Market Share by Regions: 2022 VS 2029
Figure 4. Global Nuclear Drug for Therapeutic Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Nuclear Drug for Therapeutic Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Nuclear Drug for Therapeutic Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Nuclear Drug for Therapeutic Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Nuclear Drug for Therapeutic Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Nuclear Drug for Therapeutic Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of Radium-223
Figure 11. Global Radium-223 Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Lutetium-177
Figure 13. Global Lutetium-177 Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Product Picture of Iodine-131
Figure 15. Global Iodine-131 Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 16. Product Picture of Other
Figure 17. Global Other Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 18. Global Nuclear Drug for Therapeutic Market Size Share by Type: 2022 & 2029
Figure 19. North America Nuclear Drug for Therapeutic Revenue Market Share by Type (2018-2029)
Figure 20. Europe Nuclear Drug for Therapeutic Revenue Market Share by Type (2018-2029)
Figure 21. Asia-Pacific Nuclear Drug for Therapeutic Revenue Market Share by Type (2018-2029)
Figure 22. Latin America Nuclear Drug for Therapeutic Revenue Market Share by Type (2018-2029)
Figure 23. Middle East and Africa Nuclear Drug for Therapeutic Revenue Market Share by Type (2018-2029)
Figure 24. Thyroid Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 25. Bone Metastasis Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 26. Lymphoma Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 27. Other Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 28. Global Nuclear Drug for Therapeutic Market Size Share by Application: 2022 & 2029
Figure 29. North America Nuclear Drug for Therapeutic Revenue Market Share by Application (2018-2029)
Figure 30. Europe Nuclear Drug for Therapeutic Revenue Market Share by Application (2018-2029)
Figure 31. Asia-Pacific Nuclear Drug for Therapeutic Revenue Market Share by Application (2018-2029)
Figure 32. Latin America Nuclear Drug for Therapeutic Revenue Market Share by Application (2018-2029)
Figure 33. Middle East and Africa Nuclear Drug for Therapeutic Revenue Market Share by Application (2018-2029)
Figure 34. Nuclear Drug for Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 35. Global Top 5 and Top 10 Players Nuclear Drug for Therapeutic Market Share in 2022
Figure 36. North America Nuclear Drug for Therapeutic Market Share by Country (2018-2029)
Figure 37. United States Nuclear Drug for Therapeutic Market Size (2018-2029) & (US$ Million)
Figure 38. Canada Nuclear Drug for Therapeutic Market Size (2018-2029) & (US$ Million)
Figure 39. Germany Nuclear Drug for Therapeutic Market Size (2018-2029) & (US$ Million)
Figure 40. France Nuclear Drug for Therapeutic Market Size (2018-2029) & (US$ Million)
Figure 41. U.K. Nuclear Drug for Therapeutic Market Size (2018-2029) & (US$ Million)
Figure 42. Italy Nuclear Drug for Therapeutic Market Size (2018-2029) & (US$ Million)
Figure 43. Russia Nuclear Drug for Therapeutic Market Size (2018-2029) & (US$ Million)
Figure 44. Nordic Countries Nuclear Drug for Therapeutic Market Size (2018-2029) & (US$ Million)
Figure 45. Asia-Pacific Nuclear Drug for Therapeutic Market Share by Region (2018-2029)
Figure 46. China Nuclear Drug for Therapeutic Market Size (2018-2029) & (US$ Million)
Figure 47. Japan Nuclear Drug for Therapeutic Market Size (2018-2029) & (US$ Million)
Figure 48. South Korea Nuclear Drug for Therapeutic Market Size (2018-2029) & (US$ Million)
Figure 49. Southeast Asia Nuclear Drug for Therapeutic Market Size (2018-2029) & (US$ Million)
Figure 50. India Nuclear Drug for Therapeutic Market Size (2018-2029) & (US$ Million)
Figure 51. Australia Nuclear Drug for Therapeutic Market Size (2018-2029) & (US$ Million)
Figure 52. Latin America Nuclear Drug for Therapeutic Market Share by Country (2018-2029)
Figure 53. Mexico Nuclear Drug for Therapeutic Market Size (2018-2029) & (US$ Million)
Figure 54. Brazil Nuclear Drug for Therapeutic Market Size (2018-2029) & (US$ Million)
Figure 55. Middle East & Africa Nuclear Drug for Therapeutic Market Share by Country (2018-2029)
Figure 56. Turkey Nuclear Drug for Therapeutic Market Size (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Nuclear Drug for Therapeutic Market Size (2018-2029) & (US$ Million)
Figure 58. UAE Nuclear Drug for Therapeutic Market Size (2018-2029) & (US$ Million)
Figure 59. Bottom-up and Top-down Approaches for This Report